Size: 40 µg
Type: Synthetic peptide
Form: Lyophilized Powder
Applications: wb, ihc
For research purposes only. not for human use
Properties
Sequence
- Peptide (C)RHQLSKDGQKLTLLKE, corresponding to amino acid residues 91 - 106 of human SLC25A22 (Accession Q9H936).
Accession (Uniprot) Number Q9H936
Peptide Confirmation Confirmed by amino acid analysis and mass spectrometry.
Purity >70%
Storage Before Reconstitution Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
Reconstitution 100 µl double distilled water (DDW).
Concentration After Reconstitution 0.4 mg/ml.
Storage After Reconstitution -20°C.
Antigen Preadsorption Control 1 µg peptide per 1 µg antibody.
Standard Quality Control Of Each Lot Western blot analysis.
Applications
Demonstration of Pre-adsorption control
Western blot analysis of rat brain lysates (lanes 1 and 3) and mouse brain lysates (lanes 2 and 4):1-2. Anti-SLC25A22 (GC1) Antibody (#ANT-122), (1:500).
3-4. Anti-SLC25A22 (GC1) Antibody, preincubated with SLC25A22 (GC1) Blocking Peptide (BLP-NT122).
Western blot analysis of human MCF-7 breast adenocarcinoma cell line lysate (lanes 1 and 4), human U-87 MG glioblastoma cell line lysates (lanes 2 and 5) and human LNCaP prostate adenocarcinoma cell line lysate (lanes 3 and 6):1-3. Anti-SLC25A22 (GC1) Antibody (#ANT-122), (1:200).
4-6. Anti-SLC25A22 (GC1) Antibody, preincubated with SLC25A22 (GC1) Blocking Peptide (BLP-NT122).
Last update: 02/01/2024
